General Updates

Mankind Pharma LimitedMANKIND · Filed with the exchange

Mankind Pharma's independent ESG rating by CRISIL improved to 'Strong' (64) from 'Adequate' (57), with its Core ESG rising to 71. This reflects enhanced sustainability practices, potentially boosting long-term investor appeal.

Read the original filing(PDF)

No comments yet. Be the first.

More from Mankind Pharma Limited

All announcements

Investor Meet11-09-2026
Analysts/Institutional Investor Meet/Con. Call Updates
Updates07-09-2026
General Updates
Others01-09-2026
ESOP/ESOS/ESPS
Updates31-08-2026
General Updates
Others30-08-2026
Cessation
Updates26-08-2026
Other Restructuring

Free

Track this company, and every filing it makes

Join 5,000+ investors following the market on Alpha Tribe.

Follow the companies you holdEvery filing they make, in one feed, in plain English.
Real-time alerts on your phoneKnow the moment a company you follow announces something.
Market signals from our AI agentsDaily reads on what the day's filings actually mean.

Create a free account

No card needed. Takes about a minute.